Anúncio
Anúncio
MCRB
Seres Therapeutics, Inc.
15.29
USDPatrocinado
-0.16
-1.04%
09 de jan., 10:54 UTC -5
Abrir
Relatórios de Lucros MCRB
Rácio de surpresa positiva
MCRB separação 19 de 40 últimas estimativas.
48%
Próximo Relatório
Data do Próximo Relatório
11 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$2.17
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-100.00%
/-330.85%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/+8.50%
Seres Therapeutics, Inc. earnings per share and revenue
On 05 de nov. de 2025, MCRB reported earnings of 0.94 USD per share (EPS) for Q3 25, missing the estimate of 1.30 USD, resulting in a -28.00% surprise. Revenue reached 351.00 mil, compared to an expected --, with a 0.00% difference. The market reacted with a -7.64% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analistas forecast an EPS of -2.17 USD, with revenue projected to reach -- USD, implying an diminuir of -330.85% EPS, and diminuir of -100.00% in Revenue from the last quarter.
FAQ
What were Seres Therapeutics, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Seres Therapeutics, Inc. reported EPS of $0.94, missing estimates by -28%, and revenue of $351.00K, 0% as expectations.
How did the market react to Seres Therapeutics, Inc.'s Q3 2025 earnings?
The stock price moved down -7.64%, changed from $13.75 before the earnings release to $12.70 the day after.
When is Seres Therapeutics, Inc. expected to report next?
The next earning report is scheduled for 11 de mar. de 2026.
What are the forecasts for Seres Therapeutics, Inc.'s next earnings report?
Based on 5
analistas, Seres Therapeutics, Inc. is expected to report EPS of -$2.17 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio